“In the absence of structural heart disease….” What is it, and why does it matter in antiarrhythmic drug therapy?

James A. Reiffel, Joaquim Correia
  • American Heart Journal, September 1994, Elsevier
  • DOI: 10.1016/0002-8703(94)90644-0

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1016/0002-8703(94)90644-0